Function of p21 and its therapeutic effects in esophageal cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Esophageal cancer (EC) is a leading cause of cancer mortality globally.
• Current EC treatments have limited efficacy, necessitating novel therapeutic targets.
• Cell cycle regulators are emerging as potential targets for cancer therapy.

Purpose of the Study:

• To review the multifaceted role of p21 in tumor cells.
• To explore the potential of p21 as a therapeutic target for esophageal cancer.
• To consolidate current understanding of p21's function in EC.

Main Methods:

• Literature review of studies on p21 function in cancer.
• Analysis of research on p21's role in cell cycle regulation and apoptosis.
• Examination of evidence supporting p21's tumor-suppressive effects in EC.

Main Results:

• p21 exhibits a dual role in tumor cells, capable of inhibiting proliferation and inducing apoptosis.
• Evidence suggests p21 predominantly acts as a tumor suppressor in esophageal cancer.
• The tumor-suppressive function of p21 in EC provides a rationale for its therapeutic targeting.

Conclusions:

• p21's complex functions warrant further investigation for EC treatment.
• Targeting p21 may represent a novel and effective therapeutic strategy for esophageal cancer.
• Understanding p21's role is crucial for developing advanced EC therapies.